ENANTIGEN THERAPEUTICS, INC.

Company Information

Company Name
ENANTIGEN THERAPEUTICS, INC.
Address
3805 OLD EASTON RD
DOYLESTOWN, PA, 18902-8400
Phone
1 215-589-6350
URL
http://enantigen.com
DUNS
828761697
Number of Employees
10

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,177,154.00
4
STTR Phase I
$99,967.00
1
STTR Phase II
$738,292.00
1
Chart code to be here

Award List

  1. Novel Antimicrobial Agents Targeting Drug Resistant Bacterial Biofilms

    Amount: $99,967.00

    This project addresses two pressing problems in treating bacterial infections: the emerging resistance against current antibiotics and the role of biofilm formation in these infections. Based ona succ ...

    STTR Phase I 2009 Defense Advanced Research Projects AgencyDepartment of Defense
  2. Development of a Therapy for Dengue Virus Infection

    Amount: $282,480.00

    DESCRIPTION (provided by applicant): This is a Phase I proposal to develop a new family of imino sugars, with break through , unprecedented, potency, for the treatment of dengue virus (DENV) infectio ...

    SBIR Phase I 2009 Department of Health and Human Services
  3. Novel Antimicrobial Agents Targeting Drug Resistant Bacterial Biofilms

    Amount: $738,292.00

    This project builds on patterns derived from natural antimicrobial peptide sequences to develop novel compounds with better systemic activity, lower cytotoxicity and broader spectrum activity against ...

    STTR Phase II 2012 ArmyDepartment of Defense
  4. Development of Sulfamoylbenzamide Derivatives as Antiviral Agents against HBV Inf

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): This is a proposal to develop newly discovered sulfamoylbenzamide derivatives as therapeutic agents for the treatment of chronic hepatitis B virus (HBV) infection. ...

    SBIR Phase I 2012 Department of Health and Human Services
  5. Development of Fluorinated Sulfamoylbenzamide Derivatives as Antiviral Agents aga

    Amount: $294,674.00

    DESCRIPTION (provided by applicant): This is a phase I proposal to determine the feasibility of developing newly discovered fluorinated sulfamoylbenzamide (FSBA) derivatives as therapeutic agents for ...

    SBIR Phase I 2013 Department of Health and Human Services
  6. Neural Probe for high spatial and temporal resolution detection of cocaine and su

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): This is a proposal to implement a novel high throughput assay system to detect inhibitors of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) format ...

    SBIR Phase I 2013 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government